Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of Jan-05-2024

  1. Astria Therapeutics Inc.

    World Rank (Jan-05-2024)
    15,834
    Market Cap (Jan-05-2024)
    0.297 Billion USD
    World Rank (Jul-30-2023)
    16,829
    Market Cap (Jul-30-2023)
    0.251 Billion USD
    World Rank (Dec-25-2022)
    13,758
    Market Cap (Dec-25-2022)
    0.407 Billion USD
    Headquarters Country
  2. SOPHiA GENETICS SA

    World Rank (Jan-05-2024)
    15,258
    Market Cap (Jan-05-2024)
    0.326 Billion USD
    World Rank (Jul-30-2023)
    16,911
    Market Cap (Jul-30-2023)
    0.248 Billion USD
    World Rank (Dec-25-2022)
    18,495
    Market Cap (Dec-25-2022)
    0.183 Billion USD
    World Rank (Jan-07-2022)
    10,443
    Market Cap (Jan-07-2022)
    0.83 Billion USD
    Headquarters Country
    Company Profile
    Sophia Genetics SA is a healthcare technology company to diseases such as cancer and inherited disorders where combining genomic and phenotypic information is vital to support discoveries, treatment decisions and drug development efforts. The company annual revenue is 28.4 million USD and total assets are 132.1 million USD as on 2020. The headquarters is in Switzerland.
  3. Ovid Therapeutics

    World Rank (Jan-05-2024)
    17,262
    Market Cap (Jan-05-2024)
    0.225 Billion USD
    World Rank (Jul-30-2023)
    16,913
    Market Cap (Jul-30-2023)
    0.248 Billion USD
    World Rank (Dec-25-2022)
    20,673
    Market Cap (Dec-25-2022)
    0.120 Billion USD
    World Rank (Jan-07-2022)
    18,264
    Market Cap (Jan-07-2022)
    0.23 Billion USD
    Annual Revenue in USD
    13 Million USD
    Annual Net Income in USD
    -81 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  4. ALX Oncology Holdings Inc

    World Rank (Jan-05-2024)
    10,415
    Market Cap (Jan-05-2024)
    0.717 Billion USD
    World Rank (Jul-30-2023)
    16,993
    Market Cap (Jul-30-2023)
    0.243 Billion USD
    World Rank (Dec-25-2022)
    13,048
    Market Cap (Dec-25-2022)
    0.454 Billion USD
    World Rank (Jan-07-2022)
    10,788
    Market Cap (Jan-07-2022)
    0.78 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -83 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    ALX Oncology is a Clinical Stage Biotechnology company working on Immuno Oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. The company annual revenue is approximately 185.7 million USD. The headquarters is in USA.
  5. Regencell Bioscience Holdings Ltd

    World Rank (Jan-05-2024)
    19,846
    Market Cap (Jan-05-2024)
    0.137 Billion USD
    World Rank (Jul-30-2023)
    16,994
    Market Cap (Jul-30-2023)
    0.243 Billion USD
    World Rank (Dec-25-2022)
    14,236
    Market Cap (Dec-25-2022)
    0.380 Billion USD
    World Rank (Jan-07-2022)
    14,583
    Market Cap (Jan-07-2022)
    0.42 Billion USD
    Headquarters Country
  6. Eagle Pharmaceuticals

    World Rank (Jan-05-2024)
    23,340
    Market Cap (Jan-05-2024)
    0.068 Billion USD
    World Rank (Jul-30-2023)
    16,995
    Market Cap (Jul-30-2023)
    0.243 Billion USD
    World Rank (Dec-25-2022)
    14,240
    Market Cap (Dec-25-2022)
    0.379 Billion USD
    World Rank (Jan-07-2022)
    11,839
    Market Cap (Jan-07-2022)
    0.65 Billion USD
    Annual Revenue in USD
    171 Million USD
    Annual Net Income in USD
    -8 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Eagle Pharmaceuticals is a Specialty Pharmaceutical company. It is working on advance safe and efficient injectable treatments for patients across oncology, critical care and orphan diseases. The company annual revenue is 195.9 million USD and 108 employees as on 2019. The headquarters is in USA.
  7. Verrica Pharmaceuticals

    World Rank (Jan-05-2024)
    16,042
    Market Cap (Jan-05-2024)
    0.286 Billion USD
    World Rank (Jul-30-2023)
    17,040
    Market Cap (Jul-30-2023)
    0.242 Billion USD
    World Rank (Dec-25-2022)
    21,504
    Market Cap (Dec-25-2022)
    0.103 Billion USD
    World Rank (Jan-07-2022)
    17,721
    Market Cap (Jan-07-2022)
    0.25 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -43 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  8. Inflarx

    World Rank (Jan-05-2024)
    21,019
    Market Cap (Jan-05-2024)
    0.108 Billion USD
    World Rank (Jul-30-2023)
    17,056
    Market Cap (Jul-30-2023)
    0.241 Billion USD
    World Rank (Dec-25-2022)
    19,780
    Market Cap (Dec-25-2022)
    0.144 Billion USD
    World Rank (Jan-07-2022)
    20,092
    Market Cap (Jan-07-2022)
    0.17 Billion USD
    Headquarters Country
  9. Fulcrum Therapeutics

    World Rank (Jan-05-2024)
    13,136
    Market Cap (Jan-05-2024)
    0.458 Billion USD
    World Rank (Jul-30-2023)
    17,105
    Market Cap (Jul-30-2023)
    0.238 Billion USD
    World Rank (Dec-25-2022)
    15,206
    Market Cap (Dec-25-2022)
    0.325 Billion USD
    World Rank (Jan-07-2022)
    12,092
    Market Cap (Jan-07-2022)
    0.62 Billion USD
    Annual Revenue in USD
    19 Million USD
    Annual Net Income in USD
    -80 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Fulcrum Therapeutics is a Clinical Stage Biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need with an initial focus on rare diseases. The company annual revenue is 8.82 million USD and 432 employees as on 2020. The headquarters is in USA.
  10. I-MAB

    World Rank (Jan-05-2024)
    18,548
    Market Cap (Jan-05-2024)
    0.177 Billion USD
    World Rank (Jul-30-2023)
    17,107
    Market Cap (Jul-30-2023)
    0.238 Billion USD
    World Rank (Dec-25-2022)
    15,966
    Market Cap (Dec-25-2022)
    0.289 Billion USD
    World Rank (Jan-07-2022)
    4,633
    Market Cap (Jan-07-2022)
    3.18 Billion USD
    Annual Revenue in USD
    13 Million USD
    Annual Net Income in USD
    -339 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    I-Mab is a Clinical Stage Biopharmaceutical company. It is committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company annual revenue is 114.5 million USD. The headquarters is in China.

Share

Ads